|
|
|||||||||
(Pediatrics in Review. 2007;28:397-398.)
© 2007 American Academy of Pediatrics
In Brief |
| The first 20% of the full text of this article appears below. |
Pharmacologic Considerations in Antimicrobial Therapy, With Emphasis on Pharmacokinetics and Pharmacodynamics: Reviews for the Practicing Clinician. McKinnon PS, Yu VL.
Eur J Clin Microbiol Infect Dis. 2004;23
:231
–232[CrossRef][Medline]
Antibacterial Agents in Pediatrics. Bowlware KL, Stull T.
Infect Dis Clin North Am. 2004;18
:513
–531[CrossRef][Medline]
The Therapeutic Monitoring of Antimicrobial Agents. Begg EJ, Barclay ML, Kirkpatrick CJM.
Br J Clin Pharmacol. 1999;47
:23
–30[CrossRef][Medline]
Once- Versus Twice-daily Gentamicin Dosing in Neonates
34 Weeks Gestation: Cost-effectiveness Analyses. Thureen PJ, Reiter PD, Gresores A, Stolpman NM, Kawato K, Hall DM.
Pediatrics. 1999;103
:594
–598
Pharmacokinetics describes, in mathematical terms, what the body does to an administered drug: its absorption, distribution, metabolism, and elimination. A very important linked process, pharmacodynamics, describes what an administered drug does to microorganisms and to the body: its effects and toxicity. Awareness of these principles is essential in optimizing the efficacy of drug therapy while minimizing drug-related toxicity.
When considering antimicrobial agents, it is important to recognize several factors in pediatric patients that influence
John M. Olsson, MD
Brody School of Medicine East Carolina University Greenville, NC
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | CME | ARCHIVE | SEARCH | TABLE OF CONTENTS |